| Kimberly Sumbler, | |
|
3000 S Macarthur Dr, Alexandria, LA 71301-2927 | |
| (318) 448-6800 | |
| (318) 448-6999 |
| Full Name | Kimberly Sumbler |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 8 Years |
| Location | 3000 S Macarthur Dr, Alexandria, Louisiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497200158 | NPI | - | NPPES |
| 2449150 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | AP08980 (Louisiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Christus St Frances Cabrini Hospital | Alexandria, LA | Hospital |
| Entity Name | C H Wilkinson Physician Network |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457382947 PECOS PAC ID: 8921919580 Enrollment ID: O20070911000793 |
News Archive
The U.S. Food and Drug Administration today approved a new indication for BioThrax (Anthrax Vaccine Adsorbed) to prevent disease following suspected or confirmed exposure to Bacillus anthracis, the bacterium that causes anthrax disease. The vaccine's new use is approved for people 18 through 65 years of age in conjunction with recommended antibiotic treatment. BioThrax was initially approved by the FDA in 1970 for the prevention of anthrax disease in persons at high risk of exposure.
Occlutech GmbH, the leading European developer of minimally invasive implants for the treatment of structural heart disease, today announced receiving a favourable appeal court ruling from The Hague, The Netherlands in the on-going patent litigation with AGA Medical. A favourable first instance court ruling obtained by Occlutech had been appealed by AGA in 2008.
News outlets continue to report on the science discussed at the Conference on Retroviruses and Opportunistic Infections (CROI), which ended Friday in San Francisco.
LSE Health at the London School of Economics and Political Science is leading a consortium of 15 institutional partners awarded $4.59 million Euros by the European Commission under the Horizon2020 Framework Programme for a new 3-year project entitled IMPACT HTA (Health Technology Assessment), commencing in January 2018.
In the first quarter of this year nearly 300 children across Australia fell ill with fevers, vomiting and convulsions following administration of the seasonal flu vaccine.
› Verified 6 days ago
| Entity Name | Christus Trinity Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285684225 PECOS PAC ID: 3072426741 Enrollment ID: O20200910000388 |
News Archive
The U.S. Food and Drug Administration today approved a new indication for BioThrax (Anthrax Vaccine Adsorbed) to prevent disease following suspected or confirmed exposure to Bacillus anthracis, the bacterium that causes anthrax disease. The vaccine's new use is approved for people 18 through 65 years of age in conjunction with recommended antibiotic treatment. BioThrax was initially approved by the FDA in 1970 for the prevention of anthrax disease in persons at high risk of exposure.
Occlutech GmbH, the leading European developer of minimally invasive implants for the treatment of structural heart disease, today announced receiving a favourable appeal court ruling from The Hague, The Netherlands in the on-going patent litigation with AGA Medical. A favourable first instance court ruling obtained by Occlutech had been appealed by AGA in 2008.
News outlets continue to report on the science discussed at the Conference on Retroviruses and Opportunistic Infections (CROI), which ended Friday in San Francisco.
LSE Health at the London School of Economics and Political Science is leading a consortium of 15 institutional partners awarded $4.59 million Euros by the European Commission under the Horizon2020 Framework Programme for a new 3-year project entitled IMPACT HTA (Health Technology Assessment), commencing in January 2018.
In the first quarter of this year nearly 300 children across Australia fell ill with fevers, vomiting and convulsions following administration of the seasonal flu vaccine.
› Verified 6 days ago
| Entity Name | Earl Sumbler Memorial Healthcare Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679232524 PECOS PAC ID: 6305213570 Enrollment ID: O20221031002366 |
News Archive
The U.S. Food and Drug Administration today approved a new indication for BioThrax (Anthrax Vaccine Adsorbed) to prevent disease following suspected or confirmed exposure to Bacillus anthracis, the bacterium that causes anthrax disease. The vaccine's new use is approved for people 18 through 65 years of age in conjunction with recommended antibiotic treatment. BioThrax was initially approved by the FDA in 1970 for the prevention of anthrax disease in persons at high risk of exposure.
Occlutech GmbH, the leading European developer of minimally invasive implants for the treatment of structural heart disease, today announced receiving a favourable appeal court ruling from The Hague, The Netherlands in the on-going patent litigation with AGA Medical. A favourable first instance court ruling obtained by Occlutech had been appealed by AGA in 2008.
News outlets continue to report on the science discussed at the Conference on Retroviruses and Opportunistic Infections (CROI), which ended Friday in San Francisco.
LSE Health at the London School of Economics and Political Science is leading a consortium of 15 institutional partners awarded $4.59 million Euros by the European Commission under the Horizon2020 Framework Programme for a new 3-year project entitled IMPACT HTA (Health Technology Assessment), commencing in January 2018.
In the first quarter of this year nearly 300 children across Australia fell ill with fevers, vomiting and convulsions following administration of the seasonal flu vaccine.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kimberly Sumbler, 3000 S Macarthur Dr, Alexandria, LA 71301-2927 Ph: (318) 448-6800 | Kimberly Sumbler, 3000 S Macarthur Dr, Alexandria, LA 71301-2927 Ph: (318) 448-6800 |
News Archive
The U.S. Food and Drug Administration today approved a new indication for BioThrax (Anthrax Vaccine Adsorbed) to prevent disease following suspected or confirmed exposure to Bacillus anthracis, the bacterium that causes anthrax disease. The vaccine's new use is approved for people 18 through 65 years of age in conjunction with recommended antibiotic treatment. BioThrax was initially approved by the FDA in 1970 for the prevention of anthrax disease in persons at high risk of exposure.
Occlutech GmbH, the leading European developer of minimally invasive implants for the treatment of structural heart disease, today announced receiving a favourable appeal court ruling from The Hague, The Netherlands in the on-going patent litigation with AGA Medical. A favourable first instance court ruling obtained by Occlutech had been appealed by AGA in 2008.
News outlets continue to report on the science discussed at the Conference on Retroviruses and Opportunistic Infections (CROI), which ended Friday in San Francisco.
LSE Health at the London School of Economics and Political Science is leading a consortium of 15 institutional partners awarded $4.59 million Euros by the European Commission under the Horizon2020 Framework Programme for a new 3-year project entitled IMPACT HTA (Health Technology Assessment), commencing in January 2018.
In the first quarter of this year nearly 300 children across Australia fell ill with fevers, vomiting and convulsions following administration of the seasonal flu vaccine.
› Verified 6 days ago
Stefanie Harris Corley, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 211 4th St, Alexandria, LA 71301 Phone: 318-545-0655 | |
Melanie Leonard Taylor, APRN, NP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 3000 S Macarthur Dr, Alexandria, LA 71301 Phone: 318-448-6800 | |
Lisa Latel Lee, APRN, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 501 Medical Center Dr # 250, Alexandria, LA 71301 Phone: 318-473-4613 | |
Nancy Carol Grass-ferguson, N.P. Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 44 Versailles Blvd, Alexandria, LA 71303 Phone: 318-201-5307 Fax: 318-484-4800 | |
Mrs. Heather Renee Rachal, CPNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 217 Brevard Ct Ste D, Alexandria, LA 71303 Phone: 318-777-6887 | |
Tracie Givens, NP-C Nurse Practitioner Medicare: May Accept Medicare Assignments Practice Location: 3704 North Blvd Ste D, Alexandria, LA 71301 Phone: 318-528-3200 Fax: 318-528-3201 | |
Mrs. Laura Elizabeth Williamson, APRN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 501 Medical Center Dr Ste 100, Alexandria, LA 71301 Phone: 318-487-1358 Fax: 318-487-9584 |